Clinical trial
WelChol® and Insulin in Treating Patients With Type 2 Diabetes
NCT00151749 · Daiichi Sankyo, Industry · Completed
Key facts
| NCT number | NCT00151749 |
|---|---|
| Title | WelChol® and Insulin in Treating Patients With Type 2 Diabetes |
| Official title | A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of WelChol® in Type 2 Diabetes With Inadequate Glycemic Control on Insulin Therapy Alone or Insulin Therapy Combination With Other Oral Anti-diabetic Agents |
| Lead sponsor | Daiichi Sankyo, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | Colesevelam hydrochloride |
| Enrollment | 260 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 9, 2005 |
| Last update posted | Jan 18, 2012 |
| Countries | Mexico, Peru, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: